Skip to main content

Table 2 Distribution of EGFR, HIF1α,VEGF-A and CAIX for prostate cancer patients (  n  = 103) treated with RT, with or without ADT

From: The prognostic value of expression of HIF1α, EGFR and VEGF-A, in localized prostate cancer for intermediate- and high-risk patients treated with radiation therapy with or without androgen deprivation therapy

 

n (%)

EGFR

 

 negative

42(40.8)

 weak

35 (34.0)

 strong

26 (25.2)

HIF1α (nuclear staining)

 

 No staining

9 (8.7)

 < 10%

3 (2.9)

 10 – 50%

9 (8.7)

 > 50

81 (78.6)

 NA

1 (1)

VEGF-A

 

 low

27 (26.2)

 high

76 (73.8)

CA-IX

 

 negative

103 (100.0)

 positive

0 (0)

  1. RT radiotherapy; ADT anti-androgen deprivation therapy; NA not assessable.
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us